(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary)

Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceuticals Pricing Authority

New Delhi, Dated : 17th November, 2009

ORDER

S.O. 2935(E) :-The National Pharmaceutical Pricing Authority’s Order No. S.O. 727(E) dated the 12th March, 2009, published in the Gazette of India, Extraordinary, of the Entry at Sl. No. 9 & 10 in the column No. (1) & (2) of the table, both in Hindi & English version be read as follows :

Instead of

“9. Insulin Injection
Biphasic Isophane Ph. EUR 100IU
Each ml contains
Human Insulin Ph. Eur 100IU
(Human Insulin rDNA Origin)
M- Cresol USP 0.25% w/v
Water for Injection Q.S.

10. Insulin Injection
Biphasic Isophane Ph. EUR 100IU
Each ml contains
Human Insulin Ph. Eur 100IU
(Human Insulin rDNA Origin)
M- Cresol -.16% w/v
Phenol -0.065% w/v
Water for Injection Q.S.”

Read as

“9. Insulin Injection
Soluble IP (Neutral) 100IU
Each ml contains
Human Insulin IP – 100IU
(Human Insulin rDNA Origin)
M- Cresol USP 0.25% w/v
Water for Injection IP Q.S.

10. Insulin Injection
Isophane IP 100IU
Each ml contains
Human Insulin IP – 100IU
(Human Insulin rDNA Origin)
M- Cresol USP -0.16% w/v
Phenol IP -0.065% w/v
Water for Injection IP Q.S.”

PN/112/2009/F

F. No. 8(21)/2009/D.P./NPPA-Div.II

(MANISH GOSWAMI)
Deputy Director
National Pharmaceutical Pricing Authority